Skip to content

A study of efficacy of plant-derived product in female with voiding dysfunction.

A study of efficacy of plant-derived product in female with voiding dysfunction. - A study of efficacy of plant-derived product in female with voiding dysfunction.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000026596
Enrollment
84
Registered
2019-02-28
Start date
2017-03-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

plant-derived product 28g per day for 8 weeks placebo-controlled food 28g per day for 8 weeks

Sponsors

TTC Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Females who are age from 20 to 80.

Exclusion criteria

Exclusion criteria: 1) LUTS/OAB patients or subjects who need to treatment of disease. 2) Subjects who have the habit of taking test food. 3) Subjects who have the habit of taking healthcare products. 4) Subjects who have a habit of binge drinking. 5) Patients who have serious disease or subjects who have serious disease history. 6) Subjects who take warfarin potassium or antacid. 7) Subjects who has allergies to plants. 8) Urinary calculus or bladder calculus. 9) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination. 10) Females who are known or suspected to be pregnant, breastfeeding or desire to become pregnant during the trial period. 11) Subjects who are participated in other clinical studies. 12) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. 13) Subjects who are judged unfit to enroll in this trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Bladder diary

Secondary

MeasureTime frame
OABSS,N-QOL,PSQI-j

Countries

Japan

Contacts

Public ContactHiroko Kageyama

Marukai Corporation Sale dept.

hiroko_kageyama@marukai.co.jp06-6443-0073

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026